RIVA-Fluoxetine 10 mg capsule recall in Canada: product quality issue
In plain language
This recall involves RIVA-Fluoxetine 10 mg capsules sold in Canada. It's being recalled because affected lots may exceed the acceptable limit for N-nitroso-fluoxetine. Consult your healthcare provider before discontinuing use of the product.
What to do
- Verify if your product is affected by checking the lot number.
- Consult your healthcare provider prior to discontinuing use.
- Contact Laboratoire Riva if you have questions.
- Report any health product related side effects to Health Canada.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
RIVA-Fluoxetine 10 mg capsule
Lot: D2271, D3262
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: D2271, D3262
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
This recall involves RIVA-Fluoxetine 10 mg capsules sold in Canada. It's being recalled because affected lots may exceed the acceptable limit for N-nitroso-fluoxetine. Consult your healthcare provider before discontinuing use of the product.
What should consumers do?
Verify if your product is affected by checking the lot number. Consult your healthcare provider prior to discontinuing use. Contact Laboratoire Riva if you have questions. Report any health product related side effects to Health Canada.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.
When was this product recalled?
This product was recalled on July 3, 2025.
Is the Laboratoire Riva brand affected by this recall?
Yes, Laboratoire Riva products are affected by this recall. This recall involves RIVA-Fluoxetine 10 mg capsules sold in Canada. It's being recalled because affected lots may exceed the acceptable limit for N-nitroso-fluoxetine. Consult your healthcare provider before discontinuing use of the product.